Literature DB >> 3814483

Lung cancer and women: results of a French case-control study.

E Benhamou, S Benhamou, R Flamant.   

Abstract

Ninety-six women with histologically confirmed lung cancer and 192 matched controls were involved in an international case-control study conducted from 1976 to 1980. The aim of this study was an examination of the effects of different smoking habits, especially the type of cigarettes smoked (light or dark tobacco and filter or nonfilter use) on the occurrence of lung cancer in French females. All these patients were either nonsmokers or lifetime cigarette smokers. Matched relative risk (RR) of smokers compared to nonsmokers was found to be increased for both Kreyberg I (RR = 6.6) and Kreyberg II (RR = 2.1) categories; however, this increase was significant (P less than 0.0001) only for Kreyberg I lung cancer. A significant increase (P less than 0.0001) in matched RR was found with early age at first cigarette smoked, daily consumption, duration of smoking, frequency of inhalation, use of dark tobacco and use of nonfilter cigarettes. Matched RR associated with smokers not always using dark tobacco and those smoking only dark tobacco as compared to nonsmokers were significantly increased (trend test P less than 0.0001). On the contrary, the increase of RR was not significant when either daily consumption, or duration of smoking, or age at first cigarette was taken into account. Lung cancer appeared to be associated with daily consumption and use of nonfilter cigarettes in a matched logistic regression.

Entities:  

Mesh:

Year:  1987        PMID: 3814483      PMCID: PMC2001559          DOI: 10.1038/bjc.1987.19

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  Assessment of lung cancer risk factors by histologic category.

Authors:  J H Lubin; W J Blot
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

2.  Patterns of lung cancer risk according to type of cigarette smoked.

Authors:  J H Lubin; W J Blot; F Berrino; R Flamant; C R Gillis; M Kunze; D Schmahl; G Visco
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

3.  [A major cause of epidemics: the increase in tobacco consumption in France].

Authors:  C Hill; R Flamant
Journal:  Rev Epidemiol Sante Publique       Date:  1985       Impact factor: 1.019

4.  Lung-cancer deaths: equality by 2000?

Authors:  P M Starzyk
Journal:  N Engl J Med       Date:  1983-05-26       Impact factor: 91.245

5.  Age-adjusted death rates of malignant neoplasms of various sites for 33 selected countries in the world.

Authors:  T Hirohata; A Yoshida; A Shibata
Journal:  Kurume Med J       Date:  1982

Review 6.  Smoking and lung cancer: an overview.

Authors:  L A Loeb; V L Ernster; K E Warner; J Abbotts; J Laszlo
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

7.  Lung cancer and use of cigarettes: a French case-control study.

Authors:  S Benhamou; E Benhamou; M Tirmarche; R Flamant
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

  7 in total
  4 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

2.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

3.  Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8.

Authors:  Jeffrey E Harris; Michael J Thun; Alison M Mondul; Eugenia E Calle
Journal:  BMJ       Date:  2004-01-10

4.  Changes in patterns of cigarette smoking and lung cancer risk: results of a case-control study.

Authors:  E Benhamou; S Benhamou; A Auquier; R Flamant
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.